$194.3 K

CYTX Mkt cap, 16-Aug-2018
Cytori Therapeutics Net income (Q3, 2018)-2.3 M
Cytori Therapeutics EBIT (Q3, 2018)-1.5 M
Cytori Therapeutics Cash, 30-Sep-20186.8 M

Cytori Therapeutics Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

7.1m5.0m4.8m4.7m

Revenue growth, %

(30%)(2%)(4%)

Cost of goods sold

3.4m2.9m3.2m2.7m

Gross profit

3.7m2.0m1.7m1.9m

Gross profit Margin, %

52%41%34%42%

Sales and marketing expense

9.0m6.4m2.7m3.6m3.6m

R&D expense

17.1m15.1m19.0m16.2m11.7m

General and administrative expense

16.0m16.0m9.8m8.6m7.6m

Operating expense total

42.1m37.5m31.4m28.4m24.6m

Depreciation and amortization

1.2m

EBIT

(30.7m)(32.4m)(15.3m)(19.7m)(20.7m)

EBIT margin, %

(431%)(655%)(316%)(423%)

Interest expense

3.4m4.4m3.4m2.6m2.0m

Interest income

4.0k6.0k9.0k19.0k33.0k

Net Income

(26.2m)(37.4m)(18.7m)(22.0m)(22.7m)

Cytori Therapeutics Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

15.5m14.6m14.3m12.6m9.6m

Accounts Receivable

Inventories

3.7m4.3m3.7m3.2m

Current Assets

24.6m21.7m21.2m18.7m14.9m

PP&E

1.1m1.6m1.6m1.2m3.1m

Goodwill

3.9m3.9m3.9m3.9m3.9m

Total Assets

42.1m38.7m37.7m34.6m31.6m

Accounts Payable

6.1m5.5m6.7m5.9m4.8m

Short-term debt

Current Liabilities

14.9m15.9m8.4m12.5m18.4m

Long-term debt

Total Debt

Total Liabilities

38.9m25.5m23.6m18.6m

Additional Paid-in Capital

303.7m331.8m368.0m388.8m413.3m

Retained Earnings

(300.9m)(338.3m)(357.0m)(379.1m)(401.7m)

Total Equity

3.1m11.0m13.0m

Financial Leverage

13.4 x3.2 x2.4 x

Cytori Therapeutics Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(26.2m)(37.4m)(18.7m)(22.0m)(22.7m)

Depreciation and Amortization

1.6m779.0k1.1m1.2m2.2m

Accounts Receivable

(1.2m)2.1m328.0k(179.0k)1.1m

Inventories

(459.0k)(815.0k)490.0k471.0k251.0k

Accounts Payable

(409.0k)(1.1m)1.0m(673.0k)(1.8m)

Cash From Operating Activities

(34.6m)(30.3m)(20.5m)(19.5m)(18.1m)

Purchases of PP&E

(519.0k)(764.0k)(611.0k)(67.0k)

Cash From Investing Activities

3.7m(1.3m)(613.0k)64.0k(1.7m)

Dividends Paid

(75.0k)

Cash From Financing Activities

20.8m30.9m20.8m17.6m16.8m

Interest Paid

2.3m2.6m2.0m1.6m1.4m

Cytori Therapeutics Ratios

USDY, 2018

Financial Leverage

4.2 x
Report incorrect company information

Cytori Therapeutics Employee Rating

2.918 votes
Culture & Values
3.6
Work/Life Balance
3.3
Senior Management
2.6
Salary & Benefits
2.7
Career Opportunities
3.1
Source